Get started
Author

Tatsuro Jo

Treatment and survival among 1594 patients with ATL
2015 · Hiroo Katsuya, Kenji Ishitsuka, et al. · Blood · 328
PDF
Dose‐intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: a randomized phase II study
2015 · Takashi Ishida, Tatsuro Jo, et al. · British Journal of Haematology · 273
PDF
Prognostic Index for Acute- and Lymphoma-Type Adult T-Cell Leukemia/Lymphoma
2012 · Hiroo Katsuya, Takeharu Yamanaka, et al. · Journal of Clinical Oncology · 207
PDF
Multicenter Phase II Study of Lenalidomide in Relapsed or Recurrent Adult T-Cell Leukemia/Lymphoma: ATLL-002
2016 · Takashi Ishida, Hiroshi Fujiwara, et al. · Journal of Clinical Oncology · 157
Mogamulizumab for relapsed adult T‐cell leukemia–lymphoma: Updated follow‐up analysis of phase I and II studies
2017 · Takashi Ishida, Atae Utsunomiya, et al. · Cancer Science · 71
PDF
Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial
2025 · Won Seog Kim, Tae Min Kim, et al. · Nature Cancer · 68
PDF
Prognostic index for chronic- and smoldering-type adult T-cell leukemia-lymphoma
2017 · Hiroo Katsuya, Mototsugu Shimokawa, et al. · Blood · 67
Oral histone deacetylase inhibitor tucidinostat ( HBI ‐8000) in patients with relapsed or refractory adult T‐cell leukemia/lymphoma: Phase IIb results
2022 · Atae Utsunomiya, Koji Izutsu, et al. · Cancer Science · 53
PDF
Sweet's Syndrome in Patients with MDS and MEFV Mutations
2015 · Tatsuro Jo, Kensuke Horio, et al. · New England Journal of Medicine · 52
PDF
Mogamulizumab for adult T-cell leukemia-lymphoma: a multicenter prospective observational study
2020 · Kentaro Yonekura, Shigeru Kusumoto, et al. · Blood Advances · 41
Follow‐up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T‐cell leukaemia‐lymphoma: impact on allogeneic haematopoietic stem cell transplantation
2018 · Takashi Ishida, Tatsuro Jo, et al. · British Journal of Haematology · 36
Outcomes after R-CHOP in patients with newly diagnosed advanced follicular lymphoma: a 10-year follow-up analysis of the JCOG0203 trial
2018 · Takashi Watanabe, Kensei Tobinai, et al. · The Lancet Haematology · 23
Cyclophosphamide-induced Cardiotoxicity with a Prolonged Clinical Course Diagnosed on an Endomyocardial Biopsy
2013 · Saburo Kusumoto, Hiroaki Kawano, et al. · Internal Medicine · 20
PDF
Randomized phase II study of mogamulizumab (KW-0761) plus VCAP-AMP-VECP (mLSG15) versus mLSG15 alone for newly diagnosed aggressive adult T-cell leukemia-lymphoma (ATL).
2013 · Tatsuro Jo, Takashi Ishida, et al. · Journal of Clinical Oncology · 17
Long‑lasting memory of cellular immunity in a chronic myeloid leukemia patient maintains molecular response 5 after cessation of dasatinib
2017 · Tatsuro Jo, Kazuhiro Noguchi, et al. · Oncology Letters · 16
Mogamulizumab Plus EPOCH Therapy for Patients With Newly Diagnosed Aggressive Adult T-cell Leukemia/lymphoma
2020 · TATSURO JO, KAORI MATSUZAKA, et al. · Anticancer Research · 13
PDF
Live attenuated VZV vaccination induces antitumor immunity in ATLL patients
2022 · Tatsuro Jo, Ritsuko Kubota-Koketsu, et al. · Cancer Immunology Immunotherapy · 9
PDF
HTLV ‐1 Tax‐specific memory cytotoxic T lymphocytes in long‐term survivors of aggressive‐type adult T‐cell leukemia/lymphoma
2022 · Tatsuro Jo, Kazuhiro Noguchi, et al. · Cancer Medicine · 8
Clinical features and prognosis of patients with myelodysplastic syndromes who were exposed to atomic bomb radiation in Nagasaki
2016 · Masatoshi Matsuo, Masako Iwanaga, et al. · Cancer Science · 8
PDF
Activated Memory Cytotoxic T-Lymphocytes and T-Cell Receptor Vβ Clonality Predict Treatment-Free Remission After Tyrosine Kinase Inhibitor Discontinuation in Chronic-Phase Chronic Myeloid Leukemia: A 1-Year Prospective Immuno-Monitoring Study
2026 · Tatsuro Jo, Yoshio Saburi, et al. · International Journal of Molecular Sciences · 7
PDF
Chromosomal analysis of myelodysplastic syndromes among atomic bomb survivors in Nagasaki
2017 · Makiko Horai, Shinya Satoh, et al. · British Journal of Haematology · 7
Efficacy and Cardiovascular Adverse Events of Long-term Treatment with Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia: A Report from the Nagasaki CML Study Group
2021 · Masahiko Chiwata, Hidehiro Itonaga, et al. · Internal Medicine · 6
PDF
No clear survival benefit of azacitidine for lower‐risk myelodysplastic syndromes: A retrospective study of Nagasaki
2020 · Eo Toriyama, Tomoko Hata, et al. · Cancer Science · 6
PDF
Analysis of Japanese patients from the AUGMENT phase III study of lenalidomide + rituximab (R2) vs. rituximab + placebo in relapsed/refractory indolent non-Hodgkin lymphoma
2019 · Koji Izutsu, Yosuke Minami, et al. · International Journal of Hematology · 6
Clinical significance of the immunoglobulin G heavy‐chain repertoire in peripheral blood mononuclear cells of adult T‐cell leukaemia–lymphoma patients receiving mogamulizumab
2021 · Kisato Nosaka, Shigeru Kusumoto, et al. · British Journal of Haematology · 4
PDF
Works count: 66
Citation count: 1,555
H-index: 15
I10-index: 16
Year
Topic
Type